Planned KN (NYSE: KN) Rule 144 sale covers 10,000 shares at $267,500

Rhea-AI Filing Summary

KN filed a notice under Rule 144 for a planned sale of 10,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 267,500.00. The filing lists 85,151,884 shares of common stock outstanding.

The shares to be sold were acquired from the issuer as restricted stock and performance shares on several dates from 02/12/2020 to 02/07/2025, in amounts ranging from 919 to 2,639 shares per grant. The proposed sale date is approximately 02/09/2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	267500.00	85151884	02/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/07/2025	Restricted Stock	Issuer			2532	02/07/2025	Not Applicable
Common	02/12/2020	Performance Shares	Issuer			919	02/12/2020	Not Applicable
Common	02/16/2020	Restricted Stock	Issuer			2178	02/16/2020	Not Applicable
Common	02/06/2025	Restricted Stock	Issuer			2639	02/06/2025	Not Applicable
Common	02/19/2020	Restricted Stock	Issuer			1732	02/19/2020	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the KN Form 144 filing disclose about planned share sales?

The filing discloses a planned sale of 10,000 KN common shares under Rule 144. These shares, worth 267,500.00 at the time of the notice, are expected to be sold on the NYSE through Morgan Stanley Smith Barney LLC around 02/09/2026.

How many KN shares are outstanding according to this Form 144?

The Form 144 states that 85,151,884 KN common shares are outstanding. This figure is provided as context for the planned Rule 144 sale of 10,000 shares and helps illustrate the relative size of the proposed transaction in relation to total shares.

How were the KN shares in this Rule 144 notice originally acquired?

The shares were acquired directly from the issuer as restricted stock and performance shares. Acquisition dates range from 02/12/2020 to 02/07/2025, with individual grants such as 2,532 restricted shares and 919 performance shares detailed in the filing tables.

Which broker will handle the KN Rule 144 share sale?

The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, and the transaction is designated to occur on the NYSE securities exchange.

What class of KN securities is covered by this Form 144 notice?

The notice covers common stock of KN. All listed entries in the securities information and acquisition tables identify the securities as common shares, including those received as restricted stock and performance share awards from the issuer on the specified dates.

Does the KN Form 144 mention any recent sales in the last three months?

The document includes a section for securities sold during the past three months but provides no detailed entries in the excerpt. The focus of the visible content is on the upcoming planned sale of 10,000 common shares and the historical acquisition details of those securities.